MEDIUM confidence: 100% data completeness, but the composite (59) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $11.4B— | $12.9B+13.6% | $12.0B-7.2% | $11.8B-1.7% | $12.4B+4.8% |
| EPS (dil.) | $-3.52— | $5.99n/m | $3.76-37.2% | $3.55-5.6% | $6.38+79.7% |
| Free Cash Flow | $89M— | -$36M-140.4% | $660Mn/m | $789M+19.5% | $1.1B+39.2% |
| Gross Margin | 20.8% | 17.8%-3.0pp | 20.5%+2.7pp | 21.5%+1.0pp | 18.3%-3.2pp |
| Operating Margin | 12.0% | 10.3%-1.6pp | 10.6%+0.2pp | 12.0%+1.5pp | 13.2%+1.2pp |
| Net Margin | -4.9% | 5.6%+10.5pp | 3.7%-1.9pp | 3.6%-0.2pp | 5.9%+2.3pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Buy-rated share 67% → 67% over ~3 months (+0pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $2.16 | $2.49 | +15.3% |
| Apr 2026 | $1.75 | $1.86 | +6.3% |
| Feb 2026 | $1.69 | $1.74 | +3.0% |
| Oct 2025 | $1.98 | $2.24 | +13.1% |
| Jul 2025 | $1.88 | $2.15 | +14.4% |
| Apr 2025 | $1.24 | $1.67 | +34.7% |
| Feb 2025 | $1.51 | $1.59 | +5.3% |
| Oct 2024 | $1.81 | $1.99 | +9.9% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 4.7%/yr (revenue basis).
Base free cash flow $849M (avg FY2023–FY2025; latest year $1.1B) · equity value $13.0B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net insider -$9.8M over 180 days (0 open-market buys, 7 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 59 for Crown Holdings indicates a moderately attractive stock, with the short-term score slightly outpacing the long-term score. The stock scores high on growth, driven by strong EPS growth of 80.1% and revenue growth of 4.8%, as well as momentum, with a 12-month return of 17.8% and a bullish 50-day versus 200-day moving average. However, it trades at a moderate valuation, with a P/E of 17.2, and exhibits average profitability, with an ROE of 26.5%.